{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:29:24Z","timestamp":1787621364142,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK119463"],"award-info":[{"award-number":["K23DK119463"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HL161362"],"award-info":[{"award-number":["R01HL161362"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["RL1HD107776"],"award-info":[{"award-number":["RL1HD107776"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R00HD099387"],"award-info":[{"award-number":["R00HD099387"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL151897"],"award-info":[{"award-number":["K23HL151897"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM126943"],"award-info":[{"award-number":["R35 GM126943"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM126943"],"award-info":[{"award-number":["R35 GM126943"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple organ dysfunction syndrome (MODS) is a critical driver of sepsis morbidity and mortality in children. Early identification of those at risk of death and persistent organ dysfunctions is necessary to enrich patients for future trials of sepsis therapeutics. Here, we sought to integrate endothelial and PERSEVERE biomarkers to estimate the composite risk of death or organ dysfunctions on day 7 of septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured endothelial dysfunction markers from day 1 serum among those with existing PERSEVERE data. TreeNet\u00ae classification model was derived incorporating 22 clinical and biological variables to estimate risk. Based on relative variable importance, a simplified 6-biomarker model was developed thereafter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 502 patients, 49 patients died before day 7 and 124 patients had persistence of MODS on day 7 of septic shock. Area under the receiver operator characteristic curve (AUROC) for the newly derived PERSEVEREnce model to predict death or day 7 MODS was 0.93 (0.91\u20130.95) with a summary AUROC of 0.80 (0.76\u20130.84) upon tenfold cross-validation. The simplified model, based on IL-8, HSP70, ICAM-1, Angpt2\/Tie2, Angpt2\/Angpt1, and Thrombomodulin, performed similarly. Interaction between variables\u2014ICAM-1 with IL-8 and Thrombomodulin with Angpt2\/Angpt1\u2014contributed to the models\u2019 predictive capabilities. Model performance varied when estimating risk of individual organ dysfunctions with AUROCS ranging from 0.91 to 0.97 and 0.68 to 0.89 in training and test sets, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The newly derived PERSEVEREnce biomarker model reliably estimates risk of death or persistent organ dysfunctions on day 7 of septic shock. If validated, this tool can be used for prognostic enrichment in future pediatric trials of sepsis therapeutics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-022-04070-5","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T10:02:44Z","timestamp":1657533764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective\u00a0observational\u00a0study"],"prefix":"10.1186","volume":"26","author":[{"given":"Mihir R.","family":"Atreya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Z.","family":"Cvijanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Bigham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag N.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Lutfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn R.","family":"Grunwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torrey","family":"Baines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Quasney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bereketeab","family":"Haileselassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Lindsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew N.","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector R.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"4070_CR1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","volume":"191","author":"SL Weiss","year":"2015","unstructured":"Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191:1147\u201357.","journal-title":"Am J Respir Crit Care Med"},{"key":"4070_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/CCM.0000000000004122","volume":"48","author":"JJ Zimmerman","year":"2020","unstructured":"Zimmerman JJ, Banks R, Berg RA, et al. Critical illness factors associated with long-term mortality and health related quality of life morbidity following community-acquired pediatric septic shock. Crit Care Med. 2020;48:319\u201328.","journal-title":"Crit Care Med"},{"key":"4070_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/CCM.0000000000004272","volume":"48","author":"EF Carlton","year":"2020","unstructured":"Carlton EF, Donnelly JP, Hensley MK, et al. New medical device acquisition during pediatric severe sepsis hospitalizations. Crit Care Med. 2020;48:725\u201331.","journal-title":"Crit Care Med"},{"key":"4070_CR4","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1001\/jama.2010.1553","volume":"304","author":"TJ Iwashyna","year":"2010","unstructured":"Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787\u201394.","journal-title":"JAMA"},{"key":"4070_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002198","volume":"21","author":"SL Weiss","year":"2020","unstructured":"Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020;21: e52.","journal-title":"Pediatr Crit Care Med"},{"key":"4070_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","volume":"20","author":"JC Marshall","year":"2014","unstructured":"Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20:195\u2013203.","journal-title":"Trends Mol Med"},{"key":"4070_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/MOP.0000000000000753","volume":"31","author":"MR Atreya","year":"2019","unstructured":"Atreya MR, Wong HR. Precision medicine in pediatric sepsis. Curr Opin Pediatr. 2019;31:322\u20137.","journal-title":"Curr Opin Pediatr"},{"key":"4070_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","volume":"16","author":"NL Stanski","year":"2020","unstructured":"Stanski NL, Wong HR. Prognostic and predictive enrichment in sepsis. Nat Rev Nephrol. 2020;16:20\u201331.","journal-title":"Nat Rev Nephrol"},{"key":"4070_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41581-018-0005-7","volume":"14","author":"C Lelubre","year":"2018","unstructured":"Lelubre C, Vincent J-L. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14:417\u201327.","journal-title":"Nat Rev Nephrol"},{"key":"4070_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201910-1911TR","volume":"202","author":"J Joffre","year":"2020","unstructured":"Joffre J, Hellman J, Ince C, et al. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202:361\u201370.","journal-title":"Am J Respir Crit Care Med"},{"key":"4070_CR11","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1097\/CCM.0b013e3182257675","volume":"39","author":"HR Wong","year":"2011","unstructured":"Wong HR, Cvijanovich NZ, Allen GL, et al. Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med. 2011;39:2511\u20137.","journal-title":"Crit Care Med"},{"key":"4070_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","volume":"191","author":"HR Wong","year":"2015","unstructured":"Wong HR, Cvijanovich NZ, Anas N, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med. 2015;191:309\u201315.","journal-title":"Am J Respir Crit Care Med"},{"key":"4070_CR13","doi-asserted-by":"publisher","first-page":"R174","DOI":"10.1186\/cc11652","volume":"16","author":"HR Wong","year":"2012","unstructured":"Wong HR, Salisbury S, Xiao Q, et al. The pediatric sepsis biomarker risk model. Crit Care. 2012;16:R174.","journal-title":"Crit Care"},{"key":"4070_CR14","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1097\/CCM.0000000000001852","volume":"44","author":"HR Wong","year":"2016","unstructured":"Wong HR, Cvijanovich NZ, Anas N, et al. PERSEVERE-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype. Crit Care Med. 2016;44:2010\u20137.","journal-title":"Crit Care Med"},{"key":"4070_CR15","doi-asserted-by":"publisher","unstructured":"Wong HR, Caldwell JT, Cvijanovich NZ et al. Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model. Sci Transl Med. 2019;11, doi:https:\/\/doi.org\/10.1126\/scitranslmed.aax9000.","DOI":"10.1126\/scitranslmed.aax9000"},{"key":"4070_CR16","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1164\/rccm.201911-2187OC","volume":"201","author":"NL Stanski","year":"2020","unstructured":"Stanski NL, Stenson EK, Cvijanovich NZ, et al. PERSEVERE biomarkers predict severe acute kidney injury and renal recovery in pediatric septic shock. Am J Respir Crit Care Med. 2020;201:848\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"4070_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002830","author":"AJ Lautz","year":"2021","unstructured":"Lautz AJ, Wong HR, Ryan TD, et al. Pediatric sepsis biomarker risk model biomarkers and estimation of myocardial dysfunction in pediatric septic shock. Pediatr Crit Care Med. 2021. https:\/\/doi.org\/10.1097\/PCC.0000000000002830.","journal-title":"Pediatr Crit Care Med"},{"key":"4070_CR18","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1097\/CCM.0000000000002754","volume":"46","author":"N Yehya","year":"2018","unstructured":"Yehya N, Wong HR. Adaptation of a biomarker-based sepsis mortality risk stratification tool for pediatric acute respiratory distress syndrome. Crit Care Med. 2018;46:e9-16.","journal-title":"Crit Care Med"},{"key":"4070_CR19","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/cc11145","volume":"16","author":"K Xing","year":"2012","unstructured":"Xing K, Murthy S, Liles WC, et al. Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review. Crit Care. 2012;16:R7.","journal-title":"Crit Care"},{"key":"4070_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1164\/rccm.201904-0910LE","volume":"201","author":"EF Carlton","year":"2020","unstructured":"Carlton EF, McHugh WM, McDonough K, et al. Markers of endothelial dysfunction and cytokines in high-risk pediatric patients with severe sepsis. Am J Respir Crit Care Med. 2020;201:380\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"4070_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A, et al. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2\u20138.","journal-title":"Pediatr Crit Care Med"},{"key":"4070_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0022-3476(97)70065-9","volume":"131","author":"MM Pollack","year":"1997","unstructured":"Pollack MM, Patel KM, Ruttimann UE. The pediatric risk of mortality III\u2013acute physiology score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr. 1997;131:575\u201381.","journal-title":"J Pediatr"},{"key":"4070_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/PCC.0000000000001191","volume":"18","author":"AM McIntosh","year":"2017","unstructured":"McIntosh AM, Tong S, Deakyne SJ, et al. Validation of the vasoactive-inotropic score in pediatric sepsis*. Pediatr Crit Care Med. 2017;18:750\u20137.","journal-title":"Pediatr Crit Care Med"},{"key":"4070_CR24","doi-asserted-by":"crossref","unstructured":"Le KTT, Chu X, Jaeger M et al. Leukocyte-released mediators in response to both bacterial and fungal infections trigger IFN pathways, independent of IL-1 and TNF-\u03b1, in endothelial cells. Front Immunol. 2019;10.","DOI":"10.3389\/fimmu.2019.02508"},{"key":"4070_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022248118","volume":"118","author":"H Giri","year":"2021","unstructured":"Giri H, Panicker SR, Cai X, et al. Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells. Proc Natl Acad Sci. 2021;118: e2022248118.","journal-title":"Proc Natl Acad Sci"},{"key":"4070_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41598-017-18912-8","volume":"8","author":"C Daly","year":"2018","unstructured":"Daly C, Qian X, Castanaro C, et al. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor. Sci Rep. 2018;8:505.","journal-title":"Sci Rep"},{"key":"4070_CR27","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/CCM.0000000000005139","volume":"49","author":"JC Marshall","year":"2021","unstructured":"Marshall JC, Deutschman CS. The multiple organ dysfunction syndrome: syndrome, metaphor, and unsolved clinical challenge. Crit Care Med. 2021;49:1402\u201313.","journal-title":"Crit Care Med"},{"key":"4070_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.711104","volume":"9","author":"SN Bose","year":"2021","unstructured":"Bose SN, Greenstein JL, Fackler JC, et al. Early prediction of multiple organ dysfunction in the pediatric intensive care unit. Front Pediatr. 2021;9: 711104.","journal-title":"Front Pediatr"},{"key":"4070_CR29","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/PCC.0000000000001052","volume":"18","author":"JA Carcillo","year":"2017","unstructured":"Carcillo JA, Podd B, Aneja R, et al. Pathophysiology of pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med. 2017;18:S32-45.","journal-title":"Pediatr Crit Care Med"},{"key":"4070_CR30","unstructured":"Kellum JA, Lameire N, Aspelin P et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1\u2013138."},{"key":"4070_CR31","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1542\/peds.2021-052888D","volume":"149","author":"LJ Schlapbach","year":"2022","unstructured":"Schlapbach LJ, Weiss SL, Bembea MM, et al. Scoring systems for organ dysfunction and multiple organ dysfunction: the PODIUM consensus conference. Pediatrics. 2022;149:S23-31.","journal-title":"Pediatrics"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04070-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T10:07:19Z","timestamp":1657534039000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04070-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4070"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04070-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"assertion":[{"value":"8 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from parent or guardian of patients. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review boards of participating institutions and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"M.R.A., H.R.W, and Cincinnati Children\u2019s Hospital Medical Center hold a provisional patent for the PERSEVEREnce risk model detailed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"210"}}